Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An embryonal carcinoma that arises from the ovary and occurs in children.
Biomarker and diagnostic research for childhood ovarian embryonal carcinoma has been reported in the published literature.
No clinical trials have been registered for childhood ovarian embryonal carcinoma.
6 publications have been identified in PubMed for childhood ovarian embryonal carcinoma. Research spans Case Report / Case Series (33%), Other (17%), and Diagnostic / Biomarker (17%).
Apumayta ED (2025). [PMID: 40630346](https://pubmed.ncbi.nlm.nih.gov/40630346/). *Cureus*. [Case Report / Case Series]
Masaadeh AH (2025). [PMID: 39475366](https://pubmed.ncbi.nlm.nih.gov/39475366/). *International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists*. [Case Report / Case Series]
Silva L (2025). [PMID: 40621458](https://pubmed.ncbi.nlm.nih.gov/40621458/). *Frontiers in immunology*. [Gene Therapy / Novel Therapeutics]
Bode PK (2025). [PMID: 39779499](https://pubmed.ncbi.nlm.nih.gov/39779499/). *Virchows Archiv : an international journal of pathology*. [Review / Meta-Analysis]
Santarosa Vieira AG (2024). [PMID: 38725152](https://pubmed.ncbi.nlm.nih.gov/38725152/). *Molecular oncology*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC
Christopoulos P (2024). [PMID: 39768498](https://pubmed.ncbi.nlm.nih.gov/39768498/). *J Clin Med*. [Other]